Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute
This is particularly problematic for those with chronic wounds, such as diabetic ulcers
Compounded products do not have the same safety, quality, and effectiveness assurances as FDA-approved drugs, and adulterated and misbranded injectable compounded drugs may expose patients to significant health risks, Jason Brett, executive director of medical affairs at Novo, said in a press release
35 Inappropriate Combination of GLP-1 RA The American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists advocate for the use of GLP-1 RA as supplementary therapy in combination with oral agents and insulin but advise against concomitant use with DPP4 inhibitors due to limited evidence
Firms & Smooths Skin Aids enzyme formation for rapid skin rejuvenation